SEC Form 4 · accession 0001140361-15-042195

BIOMARIN PHARMACEUTICAL INC · BMRN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Nov 16, 2015

Accepted (ET)

Nov 18, 2015 · 5:10 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001048477

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1,F2	Nov 16, 2015	S	1,050	$104.2552	D	11,850	D
Common Stock^F1	Nov 16, 2015	M	7,500	$17.33	A	19,350	D
Common Stock^F1,F3	Nov 16, 2015	S	7,500	$107.2707	A	11,850	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy) common stock^F1,F5,F4	$17.33	Nov 16, 2015	M	7,500	D	Dec 7, 2007	Jun 6, 2017	Common Stock	7,500	22,500	D

F1Trade made pursuant to a 10b5-1 plan executed on August 24, 2015.
F2The price in column 4 is an average weighted price. The price actually received ranged from $103.07 to $106.12. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3The price in column 4 is a weighted average price. The price actually received ranged from $102.98 to $106.81. The reporting person shall provide to the issuer, and security holder of the issuer, or the SEC staff upon request, information regarding the number of shares sold at each price within the range.
F4Original option grant vests 6/48ths on December 7, 2007, and 1/48th on the 7th day of every month thereafter.
F5Reflects the number of stocks options that remain outstanding from this specific stock option grant following the reported transaction.